# Lipoproteins and ImmunoMetabolism

> **NCT05746013** · NA · UNKNOWN · sponsor: **University of Seville** · enrollment: 40 (actual)

## Conditions studied

- Obesity
- Metabolic Syndrome
- Metabolism Disorder
- Inflammation
- Immune System and Related Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Lipid Emulsion

## Key facts

- **NCT ID:** NCT05746013
- **Lead sponsor:** University of Seville
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2023-05
- **Final completion:** 2025-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05746013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05746013, "Lipoproteins and ImmunoMetabolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05746013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*